FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Clears Hybrid Sacroiliac Joint Implant

FDA clears a Spinal Simplicity 510(k) for the Patriot-SI Posterior Implant System as part of a hybrid sacroiliac joint fusion construct.

latest-news-card-1
Federal Register

Guide on Public Health Emergency IVDs

Federal Register notice: FDA makes available a draft guidance entitled Enforcement Policy for Certain In Vitro Diagnostic Devices for Immediate Public...

latest-news-card-1
Federal Register

Test Enforcement Policies During Emergency Guide

Federal Register notice: FDA makes available a draft guidance entitled Consideration of Enforcement Policies for Tests During a Section 564 Declared E...

latest-news-card-1

Update Informed Consent Guidance: AdvaMed

AdvaMed calls for updates to FDA and HHS informed consent guidances.

latest-news-card-1
Human Drugs

High-Concentration Humira Biosimilar OKd

FDA approves Boehringer Ingelheims high-concentration, citrate-free formulation of Cyltezo (adalimumab-adbm), an interchangeable biosimilar to Abbvies...

latest-news-card-1
Federal Register

Info Collection on FDA Recall Regs

Federal Register notice: FDA sends to OMB an information collection extension entitled FDA Recall Regulations 21 CFR Part 7.

latest-news-card-1
Federal Register

Listening Session on Advisory Committee Revamp

Federal Register notice: FDA announces a 6/13 virtual public meeting entitled Listening Session: Optimizing FDAs Use of and Processes for Advisory Com...

latest-news-card-1
Medical Devices

QS Violations in Unapproved Spectrum Devices

FDA warns the UKs Spectrum Medical about QS violations in its production of unapproved perfusion system devices.

latest-news-card-1
Medical Devices

VITEK 2 Antimicrobial Test Cards Recalled

BioMrieux recalls its VITEK 2 AST antimicrobial sensitivity testing cards due to a higher concentration of ceftriaxone antibiotic in two wells.

latest-news-card-1
Federal Register

Draft Guide on Cell/Gene Therapy Considerations

Federal Register notice: FDA makes available a draft document entitled Considerations for the Use of Human- and Animal-Derived Materials and Component...